Some non-CKD–MBD biomarkers, such as asymmetric dimethylarginine (ADMA), resistin, and C-reactive protein (CRP), were demonstrated to be related to a number of cardiovascular diseases. Here, CRP is linked to Marchiafava-Bignami disease.